
Explore My Research
Discover my work in microbiome science, multi-omics and AI.
I am a Staff Scientist in Trevor Lawley’s group, part of the Parasites and Microbes programme, where I investigate how the gut microbiome shapes child health in low- and middle-income countries.
My current work centres on the Childhood Acute Illness and Nutrition (CHAIN) cohort, a multi-site study of acutely ill and undernourished children across six countries in sub-Saharan Africa and South Asia. I integrate longitudinal metagenomic, proteomics and metabolomic data to ask a deceptively simple question: what separates the children who recover from those who do not? Rather than analysing each data type in isolation, I build models that follow how microbial community dynamics, and try to understand host immune and metabolic responses move together over time — from hospital admission through to recovery at home.
I am drawn to problems where the biology only becomes visible when several layers of data are read at once. Longitudinal designs are demanding, but they let us move beyond correlation towards the ordering of events, which is what we need if microbiome-directed therapies are to be designed rationally rather than guessed at. This fits closely with the group’s wider effort to define how healthy, disease-resistant microbiomes develop, and to translate that understanding into cultured bacterial isolates and open genomic resources.
Before joining the Institute, I worked on the multi-omic integration of ageing. I developed computational frameworks for quantifying cellular senescence and predicting the function of transcriptional factors in tumour microenvironments and aged tissues, and investigated the role of redox and epigenetic signalling in ageing.
Ageing and early-life development sit at opposite ends of the lifespan, but both are questions about how hosts and microbes shape trajectories over time. My goal is to turn those trajectories into translations — predicting the children early enough to act on, and providing insights into microbiome-directed therapies.